CSG Advances Fuse Self-Sufficiency in Slovakia While Awaiting EU Green Light for €58bn Framework
23.05.2026 - 21:40:57 | boerse-global.de
The Czech defence group CSG is taking steps to bring a critical artillery component in-house, joining forces with South Africa’s Reunert to manufacture electronic fuses for 155mm shells at its Slovak facility. The move comes as the company’s shares stage a weekly recovery of more than 14 percent, supported by a first-quarter earnings beat that helped push back against recent short-seller allegations.
Fuchs Electronics Europe, the new joint venture, will be based at CSG’s ZVS Dubnica nad Váhom plant in Slovakia. Reunert holds a 51 percent stake, with CSG taking the remaining 49 percent. Technology will come from Fuchs Electronics, a Reunert unit that has been in the fuse business for over six decades, while CSG contributes production infrastructure, regulatory and export know-how, plus selected component manufacturing. Electronic fuses govern the timing and detonation mode of artillery rounds—impact, delay, time, and airburst—making them a strategically sensitive item for which European Union internal production has long been scarce.
The JV will supply not only CSG’s own ammunition lines but also other European makers of large-calibre munitions, positioning it as a broad supplier rather than a captive operation. Financial details remain undisclosed, but CSG described the venture as capital-efficient and supported by a binding launch order covering the first three years. Management expects the unit to break even on a standalone basis within roughly three years and to become margin?accretive for both partners. Regulatory approvals—spanning foreign investment review, competition authorities, defence clearances, and foreign exchange controls—still need to be secured before closing.
Those supply-chain ambitions sit alongside operating results that offer a counter-narrative to the scepticism stirred by US short seller Hunterbrook Media in early May. CSG’s first-quarter revenue climbed 13.8 percent year-on-year to €1.544 billion, propelled by a 26.5 percent surge in the Defence Systems segment. Adjusted EBIT came in at €372 million, translating into a margin of 24.1 percent, comfortably within management’s target band. The order backlog expanded to €17 billion, while the pipeline of potential deals stood at €27 billion. Net debt fell to €2.228 billion from €3.004 billion at year-end, reflecting improved cash generation.
Should investors sell immediately? Or is it worth buying CSG?
Hunterbrook had accused CSG of refurbishing old ammunition rather than producing new shells and raised questions about transparency around its initial public offering and shareholder structure. The company formally rejected the claims, calling them a selective interpretation of public information designed to benefit a related short position. The stock, which sank as low as €15.73 on May 4, has since climbed nearly 19 percent. By Friday’s close of €18.70 it had still surrendered 3.41 percent on the day, but the weekly gain stood at 14.14 percent. Despite the rebound, the shares remain 44.7 percent below their 52-week high of €33.80 and trade 14.63 percent below the 50-day moving average, underscoring persistent investor caution.
Not every business line is firing on all cylinders. The CSG Ammo+ segment saw revenue drop 20.5 percent to €291 million, and operating profit plunged 68.5 percent to €13 million, a decline the company attributed to difficult conditions in the US market. CSG sees the US as a source of future growth, however. It has expanded a supply relationship with the FBI, is adding 5.56mm capacity, and its MSM North America unit is pursuing a $635 million contract for planning and construction of the US Army’s Future Artillery Complex in Iowa. A new anti-drone munition compatible with NATO standard assault rifles has also been successfully tested with the Italian army.
The biggest near-term catalyst, though, may come from a completely different lever. CSG’s Slovak subsidiary, ZVS Holding, has signed a framework agreement with the country’s defence ministry covering ammunition deliveries with a potential ceiling of €58 billion. No firm purchase orders have been placed yet, and CSG stresses that the framework does not hinge on any single financing source. However, for Slovakia to access the most favourable terms under the EU’s SAFE programme—loans at 1 percent interest over 40 years—it needs at least one additional EU member state as a partner. That country?specific exemption expires at the end of May 2026. Romania has already opted out, while Croatia is still evaluating. If a second nation steps in before the deadline, CSG’s order book could receive a massive fillip.
CSG at a turning point? This analysis reveals what investors need to know now.
Analysts remain broadly constructive. The average twelve-month price target stands at €32.85, with a range from €25 to €42. Ten analysts rate the stock a buy, and none recommend selling. Credit ratings have also improved: Moody’s upgraded CSG’s secured senior debt to Baa3 from Ba1, and Fitch affirmed its BBB- rating with a stable outlook. The next scheduled hard catalyst will be the half?year results on August 7. Until then, the market will be watching whether CSG can sustain its operational momentum and convert the Slovakia framework into binding orders, while the new fuse venture adds a layer of vertical integration to its ammunition story.
Ad
CSG Stock: New Analysis - 23 May
Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
